Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Hum Hypertens ; 20(6): 392-7, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16543911

RESUMEN

This study evaluates the association between blood pressure (BP) and the risk of developing cardiovascular disease (CVD) events in the elderly. The Morton Plant Mease Foundation has followed 4,008 elderly patients >64 years of age for at least 5 years. Systolic and diastolic blood pressure (SBP and DBP) was divided into categories. Cardiovascular disease events were classified as myocardial infarction, stroke, and CVD-related deaths reported from the National Death Index. Cox proportional hazard ratios were used to assess the relationship between BP and CVD events and controlled for weight, gender, smoker, and alcohol use. Ages <75 and >or=75 years were assessed separately. After 11.1 years of follow-up, elevated SBP (P=<0.0001) is strongly associated with developing a future CVD event; the relationship is linear and graded and holds for ages above and below 75 years. The frequency of CVD events was lowest in the SBP <120 mm Hg group. In subjects <75 years of age, DBP elevations were not a significant risk factor for CVD events. (relative risk (RR): DBP 70 to <80 mm Hg=0.92; DBP 80 to <90 mm Hg=0.88; DBP >or=90 mm Hg=1.02.) With subjects >or=75 years of age, a DBP between 80 and 90 is associated with the lowest significant risk for CVD (RR: DBP 70 to <80 mm Hg=0.74; DBP 80 to <90 mm Hg=0.59; DBP >or=90=0.71). In conclusion, these findings support the Joint National Committee on Hypertension recommendations for SBP in the elderly. Further studies are warranted to identify optimal DBP for the elderly at various ages.


Asunto(s)
Presión Sanguínea/fisiología , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/fisiopatología , Anciano , Determinación de la Presión Sanguínea/métodos , Distribución de Chi-Cuadrado , Factores de Confusión Epidemiológicos , Femenino , Florida/epidemiología , Humanos , Masculino , Valor Predictivo de las Pruebas , Modelos de Riesgos Proporcionales , Medición de Riesgo
2.
Am Fam Physician ; 57(6): 1299-1306, 1307-9, 1998 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-9531913

RESUMEN

Nearly one half of Americans die of cardiovascular disease. The morbidity and mortality associated with coronary artery disease is strongly related to abnormal lipid levels, oxidation of lipids and intra-arterial clot formation. Nutrition powerfully influences each of these factors. There is growing evidence that patients can improve lipid levels and decrease the rate of cardiovascular events by "adding" specific foods to their diets and switching from saturated and polyunsaturated to monounsaturated fats and n-3 fatty acids. Appropriate dietary changes decrease arteriosclerotic plaque formation, improve endothelial vasomotor dynamics, reduce oxidation of low-density lipoproteins and enhance thrombolytic activity. Brief discussions between physicians and patients can influence patients' food choices. Changes in diet can reduce the premature mortality and morbidity associated with coronary artery disease.


Asunto(s)
Enfermedad Coronaria/dietoterapia , Enfermedad Coronaria/metabolismo , Enfermedad Coronaria/prevención & control , Grasas Insaturadas en la Dieta/administración & dosificación , Peroxidación de Lípido , LDL-Colesterol/sangre , Enfermedad Coronaria/sangre , Ácidos Grasos Omega-3/administración & dosificación , Humanos , Educación del Paciente como Asunto , Materiales de Enseñanza
3.
Am Fam Physician ; 38(2): 109-18, 1988 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-3044049

RESUMEN

Malaria should be considered in a patient with unexplained fever and a history of travel to an endemic area. Aggressive therapy must be started if Plasmodium falciparum infection is a possibility. Travelers must be educated about mosquito bite protection and appropriate chemoprophylaxis. Travelers can, however, acquire malaria despite chemoprophylaxis, and symptoms may appear up to one year after the trip.


Asunto(s)
Antimaláricos/uso terapéutico , Malaria/prevención & control , Animales , Resistencia a Medicamentos , Humanos , Malaria/tratamiento farmacológico , Malaria/parasitología , Plasmodium falciparum , Plasmodium vivax , Viaje
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA